Key facts
- This page summarizes Boswell Prayer Ltd.'s Form 3 filing for Chromocell Therapeutics Corp (CHRO).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Feb 2024, 20:38.
Boswell Prayer Ltd. - 15 Feb 2024 Form 3 Insider Report for Chromocell Therapeutics Corp (CHRO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CHRO
- Reported as of
- 15 Feb 2024
- Net transaction value
- $0
- Reporting owner signature
- Boswell Prayer Ltd., By /s/Rochelle Gross
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Boswell Prayer Ltd. filed Form 3 for Chromocell Therapeutics Corp (CHRO) on 15 Feb 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CHRO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 459,895
- Date
- 15 Feb 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CHRO
holding
Derivative
Senior Secured Convertible Promissory Note
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 15 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,697
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents $56,141.81 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due February 29, 2024, which will automatically convert into 11,697 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering.
Footnote F2
Rochelle Gross has sole voting and dispositive power over the shares held by the Reporting Person as to which Mr. Gross disclaims beneficial ownership except to the extent of his pecuniary interest therein.
SEC remarks
Exhibit 24 - Power of Attorney